SENORESSenores Pharmaceuticals Limited
Pharma · Drug Manufacturers - General · NSE · as of 2026-09-11 (delayed ~30 min in market hours)
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • Revenue growth: 38.3% YoY
- • Profit growth: 43.5% YoY
- • Debt/Equity: 0.35
- • RSI: 52
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 63%)
Bull case
- • Revenue growth: 38.3% YoY
- • Profit growth: 43.5% YoY
- • Debt/Equity: 0.35
- • RSI: 52
Bear case
- • ROCE: 10.7%
- • Dividend yield: 0.00%
- • MACD: bearish
- • Volume: 0.6x 20-day average
Key risks
- • ROCE: 10.7%
- • Dividend yield: 0.00%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹54.52). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.